CLINICAL EXPERIENCE WITH INTRAOPERATIVE FLOPPY IRIS SYNDROME

Abstract

Purpose: This study was conducted to recognise the incidence, risk factors, complications and the management of intraoperative oppy iris syndrome (IFIS). Retrospective analysis of the preoperative da Materials and Methods: ta, systemic comorbidities, medication history and intraoperative observations was conducted in 1116 eyes (of 482 males and 634 females), who underwent cataract surgery from January 2021 to June 2022. The mean age of patients was 67.08±8.18 Results: years. The incidence of IFIS observed is (44) 3.9%. 28 (84%) men with Tamsulosin dosage had IFIS features. But 16 (36%) patients who were not exposed to any alpha blockers also showed the features of IFIS. Hypertension was found to be a signicant risk factor while diabetes, coronary heart diseases were not. The mean duration of drug intake was 23.11 ± 23.42 months not affecting the severity of IFIS. Surgical difculties like posterior capsule rupture ve (11.4%) and iris prolapse were noted in six (13.6%) cases and additional measures like intracameral adrenaline, iris hooks and viscoelastic device were used to manage them. Despite the increased operative time, the surgical outcome was good in all the patients. The Conclusion: incidence of IFIS is higher in patients with intake of Tamsulosin. Its usage and hypertension were the risk factors associated. Thus it is imperative to create awareness to elicit a thorough medical history preoperatively. The critical aspects of IFIS are stratication of performative risk, prompt preoperative prophylaxis and surgical technique with the aid of mechanical and pharmacological agents. Eliciting a reliable history of current or past α1AR antagonist consumption in the presence of hypertension is essential.